Stock News
Yay! Astellas Gets Green Light from European Commission for Vyloy-Zolbetuximab Combo to Fight Advanced Stomach Cancer
Celebrating a Milestone: Zolbetuximab Approved in the EU for Gastric Cancer Treatment The Breakthrough Therapy Imagine a world where advanced gastric cancer can be treated effectively with a targeted therapy. That world is now a reality with the approval of zolbetuximab in the European Union. This groundbreaking therapy targets claudin 18.2, a biomarker expressed in…
Marvell to Showcase Optical Interconnect Innovations for Accelerated Infrastructure at ECOC 2024
Delivering Breakthrough Technologies Designed to Meet the Rising Demand for Bandwidth Across AI-Driven Data Centers and Networks SANTA CLARA, Calif. – Sept. 20, 2024 Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, will showcase its industry-leading optical technology designed to meet the rising performance demands of AI cloud data centers at…
Get the Scoop: Proactive Investors Shares Exciting Company News!
Alternus Clean Energy Inc Terminates Agreement to Acquire Solar Installations What Happened? Alternus Clean Energy Inc (NASDAQ:ALCE, OTC:ACLEW) recently announced the termination of its Membership Interest Purchase and Sales Agreement with C2 Taiyo Fund. The agreement would have allowed Alternus Clean Energy Inc to acquire approximately 80 MWp solar installations across eight US states. However,…
Revolutionizing Connected Commerce: SEALSQ Incorporates Internet of Payment (IoP) into Next-Generation IoT-Enabled Semiconductors
SEALSQ Corp Revolutionizes IoT with Internet of Payment Integration In exciting news, SEALSQ Corp has announced the integration of Internet of Payment (IoP) capabilities into its next-generation IoT-enabled semiconductor solutions. This move marks a significant step forward in the world of technology and sets SEALSQ apart as a pioneering force in the industry. The Transformation…
Breaking News: Pfizer and BioNTech’s COVID-19 Vaccine Gets Thumbs Up from CHMP in EU! Omicron-KP-2 Adaptation for the Win!
Exciting News from Pfizer and BioNTech: Omicron KP.2-adapted COVID-19 Vaccine What’s Happening? Big news in the world of COVID-19 vaccines! Pfizer and BioNTech have announced that their Omicron KP.2-adapted COVID-19 vaccine, known as COMIRNATY® KP.2, has been recommended for marketing authorization by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines…
Clever, Personable, and Unconventional: Dupixent Recommended for EU Approval to Treat Eosinophilic Esophagitis in Children as Young as 1 Year Old
Dupixent recommended for EU approval to treat eosinophilic esophagitis in children Positive Recommendation by CHMP Paris and Tarrytown, NY, September 20, 2024 – The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the expanded approval of Dupixent (dupilumab) in the European Union (EU) for the treatment…
Act Now: Investor Deadline Approaching for Vicor Corporation Shareholders with Significant Losses – Join the Fight with Robbins Geller Rudman & Dowd LLP!
Robbins Geller Rudman & Dowd LLP Announces Vicor Corporation Class Action Lawsuit Seeking Lead Plaintiff for Vicor Corporation Class Action Lawsuit San Diego, Sept. 20, 2024 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP has announced that purchasers or acquirers of Vicor Corporation (NASDAQ: VICR) common stock between April 26, 2023 and February 22,…
Experience the Future of Railways: Rail Vision’s AI-Driven Products Take Center Stage at Global Events!
Embracing Innovation in Railway Safety Exciting News in the Railway Industry On September 20, 2024, Rail Vision Ltd. announced its participation in two important events in the railway industry. The company, known for its revolutionary approach to railway safety and data-related products, is set to showcase its cutting-edge AI-based solutions and engage with industry professionals….